In our AML cohort, top-ranked genes showed convergence of cohort signal, essentiality, and pathway coherence; several understudied genes (AGTR2, NTRK1, LAG3, MPL, TERT) retained high priority after safety filtering, highlighting actionable and novel avenues for experimental validation. The gene discussed is LAG3; the disease is acute myeloid leukemia.